Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence

BACKGROUND: General transcription factor IIi (GTF2I) mutations are very common in thymic epithelial tumors (TETs) and are related to a more favorable prognosis in TET patients. However, limited research has been conducted on the role of GTF2I in the tumor immune microenvironment (TIME). Further, lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei, Yang, Hao-Shuai, Zheng, Shao-Yi, Weng, Jian-Hao, Luo, Hong-He, Lei, Yi-Yan, Feng, Yan-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482307/
https://www.ncbi.nlm.nih.gov/pubmed/36114454
http://dx.doi.org/10.1186/s12864-022-08880-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482307/
https://www.ncbi.nlm.nih.gov/pubmed/36114454
http://dx.doi.org/10.1186/s12864-022-08880-3

Ejemplares similares